Marked regression of myelofibrosis during reduced-dose dasatinib treatment in chronic myelogenous leukemia in accelerated phase. [electronic resource]

By: Contributor(s): Producer: 20161013Description: 219-22 p. digitalISSN:
  • 1029-2403
Subject(s): Online resources: In: Leukemia & lymphoma vol. 57
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Case Reports; Letter

There are no comments on this title.

to post a comment.
Previous
Back to results
Next
Close